TITLE

Hypertension in Diabetes Mellitus: Role of β-Blockers

AUTHOR(S)
Messerli, Franz H.; Grossman, Ehud
PUB. DATE
July 2001
SOURCE
Drugs;Jul2001, Vol. 61 Issue 10
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Comments on the efficacy of several antihypertensive drugs. Reduction in cardiovascular events and cardiovascular mortality; Interrelation between beta blockers and metabolic disturbance; Complications in hypertension in relation to coronary morbidity and mortality.
ACCESSION #
4990081

 

Related Articles

  • Betting on Beta-Blockers. Wetherbee, Kris // Town & Country;Dec2001, Vol. 155 Issue 5259, p160 

    Details the role of beta-blockers in preventing hypertension.

  • BETA BLOCKERS WITH CLONIDINE? Rashid, Harooner; Cohn, Peter F. // Cortlandt Forum;9/25/2003, Vol. 16 Issue 9, p50 

    Discusses the common errors in hypertension control. Use of a beta blocker/clonidine combination in treating hypertension; Increase in blood pressure due to increased alpha tone; Danger of rebound hypertension.

  • Drugs for high blood pressure--is new necessarily better? E.B. // Medical Update;Oct95, Vol. 19 Issue 4, p4 

    Discusses the advantages of diuretics and beta blockers over calcium channel blockers and angiotensin-converting enzyme (ACE) inhibitors in treating hypertension. Effectivity of diuretics in treating persons with isolated systolic hypertension; Recommendation from the Joint National Committee...

  • New approaches to the uses of beta blocking drugs in hypertension. Prichard, B N C; Graham, B R; Cruickshank, J M // Journal of Human Hypertension;Apr2000 Supplement, Vol. 14 Issue 4, pS63 

    After a slow start, beta-blockers have become widely used as first-line agents in the treatment of hypertension, and recommended as such in recently published guidelines. There is evidence that the beta[SUB1]-selective agents are more efficacious than non-selective blockers that inhibit both...

  • β-Adrenergic Blockers in Systemic Hypertension: Pharmacokinetic Considerations Related to the Current Guidelines. Frishman, W.H.; Alwarshetty, M. // Clinical Pharmacokinetics;May2002, Vol. 41 Issue 7, p505 

    β-Adrenergic blockade has provided one of the major pharmacotherapeutic advances of the 20th century. β-Blockers are first-line drugs for the management of systemic hypertension, used alone and in combination with other antihypertensive agents. Drugs in the β-blocking class have the...

  • Post-Transplant HT Controlled by Quinapril and Atenolol.  // Kidney;Sep/Oct99, Vol. 8 Issue 5, p218 

    Discusses an abstract of the article, entitled 'ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients,' by M. Hausberg, M. Barenbrock, H. Hohage and others.

  • Are Off-Label Drugs Ever OK? Amanda, First // Runner's World;Feb2013, Vol. 48 Issue 2, p018 

    The article presents information related to the use of beta-blockers for the treatment of high blood pressure.

  • New propranolol controls A.M. blood pressure spikes. Karpa, Kelly Dowhower // Drug Topics;4/7/2003, Vol. 147 Issue 7, p14 

    Focuses on Innopran XL, a propranolol product from Reliant Pharmaceuticals and Eurand. Designation as the only beta-blocker indicated for evening administration; Control of blood pressure increase; Significance of bedtime dosing; Chronotherapeutic approach used by the drug's extended-release...

  • Hypertension in Diabetes Mellitus: Role of β-Blockers. Martin, Una; Dunne, Fidelma; Kendall, Martin // Drugs;Jul2001, Vol. 61 Issue 10 

    Examines the role of beta blockers on the treatment of hypertension in diabetes mellitus in Great Britain. Rate of heart attack in patients treated with beta blockers; Incidence of coronary artery disease in patients with hypertension and diabetes mellitus; Effects of antihypertensive therapy...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics